Find zapnometinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Zapnometinib, 303175-44-2, Zapnometinib [inn], Pd-0184264, Atr-002, 4rzd8lk83v
Molecular Formula
C13H7ClF2INO2
Molecular Weight
409.55  g/mol
InChI Key
XCNBGWKQXRQKSA-UHFFFAOYSA-N
FDA UNII
4RZD8LK83V

zapnometinib
Zapnometinib is an orally bioavailable, small molecule inhibitor of mitogen-activated protein kinase kinase (MAP2K; MAPK/ERK kinase; MEK), with potential anti-viral and anti-inflammatory activities. Upon oral administration, zapnometinib selectively binds to and inhibits the activity of MEK. This may prevent the export of the viral genome protein complexes from the nucleus to the cytoplasm, thereby inhibiting the formation of new viral particles and the replication of various RNA viruses, including influenza virus, hantavirus, respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In addition, the inhibition of the activity of MEK may also decrease gene expression and inhibit the production of proinflammatory cytokines and chemokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1-beta, IL-8, C-X-C motif chemokine 10 (interferon gamma-induced protein 10; IP-10), C-C motif chemokine 2 (monocyte chemoattractant protein-1; MCP-1) and C-C motif chemokine 3 (macrophage inflammatory protein 1-alpha; MIP-1a), thereby reducing inflammation. MEK, a dual-specificity threonine/tyrosine kinase family, plays a key role in the activation of the RAS/RAF/MEK/ERK signaling pathway. Many RNA viruses rely on this pathway inside human cells to replicate.
1 2D Structure

zapnometinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic acid
2.1.2 InChI
InChI=1S/C13H7ClF2INO2/c14-8-5-6(17)1-4-10(8)18-12-7(13(19)20)2-3-9(15)11(12)16/h1-5,18H,(H,19,20)
2.1.3 InChI Key
XCNBGWKQXRQKSA-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C=C1I)Cl)NC2=C(C=CC(=C2F)F)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
4RZD8LK83V
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-(2-chloro-4-iodophenylamino)-n-3,4-difluorobenzoic Acid

2. Atr-002

3. Atr002

2.3.2 Depositor-Supplied Synonyms

1. Zapnometinib

2. 303175-44-2

3. Zapnometinib [inn]

4. Pd-0184264

5. Atr-002

6. 4rzd8lk83v

7. Benzoic Acid, 2-[(2-chloro-4-iodophenyl)amino]-3,4-difluoro-

8. Unii-4rzd8lk83v

9. 2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic Acid

10. Atr002

11. Chembl481949

12. 2-((2-chloro-4-iodophenyl)amino)-3,4-difluorobenzoic Acid

13. 3,4-difluoro-2-((2-chloro-4-iodophenyl)amino)benzoic Acid

14. Benzoic Acid, 2-((2-chloro-4-iodophenyl)amino)-3,4-difluoro-

15. 2-[(2-chloro-4-iodophenyl)amino]-3,4-difluorobenzoic Acid

16. 3,4-difluoro-2-[(2-chloro-4-iodophenyl)amino]benzoic Acid

17. Zapnometinib [usan]

18. Schembl1488782

19. Atr 002 [who-dd]

20. Gtpl11679

21. Dtxsid80435811

22. Bcp31195

23. Ex-a7557

24. Bdbm50595935

25. Akos027447717

26. Ms-27054

27. Pd0184264; Atr-002

28. Hy-139558

29. Pd0184264

30. Cs-0204157

31. Ft-0664738

32. F77040

33. J-017908

34. 3,4-difluoro-2-(2-chloro-4-iodophenylamino)-benzoic Acid

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 409.55 g/mol
Molecular Formula C13H7ClF2INO2
XLogP35
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area49.3
Heavy Atom Count20
Formal Charge0
Complexity363
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 303175-44-2 / zapnometinib API manufacturers, exporters & distributors?

zapnometinib manufacturers, exporters & distributors 1

96

PharmaCompass offers a list of zapnometinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right zapnometinib manufacturer or zapnometinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred zapnometinib manufacturer or zapnometinib supplier.

PharmaCompass also assists you with knowing the zapnometinib API Price utilized in the formulation of products. zapnometinib API Price is not always fixed or binding as the zapnometinib Price is obtained through a variety of data sources. The zapnometinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

zapnometinib

Synonyms

303175-44-2, Zapnometinib [inn], Pd-0184264, Atr-002, 4rzd8lk83v, Benzoic acid, 2-[(2-chloro-4-iodophenyl)amino]-3,4-difluoro-

Cas Number

303175-44-2

Unique Ingredient Identifier (UNII)

4RZD8LK83V

About zapnometinib

Zapnometinib is an orally bioavailable, small molecule inhibitor of mitogen-activated protein kinase kinase (MAP2K; MAPK/ERK kinase; MEK), with potential anti-viral and anti-inflammatory activities. Upon oral administration, zapnometinib selectively binds to and inhibits the activity of MEK. This may prevent the export of the viral genome protein complexes from the nucleus to the cytoplasm, thereby inhibiting the formation of new viral particles and the replication of various RNA viruses, including influenza virus, hantavirus, respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In addition, the inhibition of the activity of MEK may also decrease gene expression and inhibit the production of proinflammatory cytokines and chemokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1-beta, IL-8, C-X-C motif chemokine 10 (interferon gamma-induced protein 10; IP-10), C-C motif chemokine 2 (monocyte chemoattractant protein-1; MCP-1) and C-C motif chemokine 3 (macrophage inflammatory protein 1-alpha; MIP-1a), thereby reducing inflammation. MEK, a dual-specificity threonine/tyrosine kinase family, plays a key role in the activation of the RAS/RAF/MEK/ERK signaling pathway. Many RNA viruses rely on this pathway inside human cells to replicate.

zapnometinib Manufacturers

A zapnometinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of zapnometinib, including repackagers and relabelers. The FDA regulates zapnometinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. zapnometinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

zapnometinib Suppliers

A zapnometinib supplier is an individual or a company that provides zapnometinib active pharmaceutical ingredient (API) or zapnometinib finished formulations upon request. The zapnometinib suppliers may include zapnometinib API manufacturers, exporters, distributors and traders.

zapnometinib GMP

zapnometinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of zapnometinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right zapnometinib GMP manufacturer or zapnometinib GMP API supplier for your needs.

zapnometinib CoA

A zapnometinib CoA (Certificate of Analysis) is a formal document that attests to zapnometinib's compliance with zapnometinib specifications and serves as a tool for batch-level quality control.

zapnometinib CoA mostly includes findings from lab analyses of a specific batch. For each zapnometinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

zapnometinib may be tested according to a variety of international standards, such as European Pharmacopoeia (zapnometinib EP), zapnometinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (zapnometinib USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty